THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK

Total received in grants · trailing 12 months
$25M
vs. GOVERNOR'S AUTHORIZED REPRESENTATIVE ($39.2B), largest tracked grant recipient
$0for every U.S. household÷ 131M U.S. households
In perspective
0.0%of all $401.9B in tracked grants
10separate grants, trailing 12 months

THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK has received $25M across 10 federal grants of $1M or more on record.

Data as of August 5, 2026. Source: USAspending.gov, prime contract awards $1M+. Federal spending data lags and has known gaps. This is not a real-time or complete record.

Grants by agency

Where this recipient’s grant dollars come from.

All grant awards

Swipe to see description and amount →

AgencyDescriptionAmount
BTO OFFICE WIDE BAA BIOLOGICAL TECHNOLOGIES OFFICEWIDE BIOLOGICAL UNDERSEA ENERGY BLUE
$5,852,651
SUPPORTING REGIONAL IMPLEMENTATION OF INTEGRATED CLIMATE RESILIENCE CONSORTIUM FOR CLIMATE RISK IN THE URBAN NORTHEAST (CCRUN) PHASE III
$5,504,764
XENOTRANSPLANTATION WITHOUT IMMUNOSUPPRESSIVE MAINTENANCE (XTWIM) - PROJECT SUMMARY XENOTRANSPLANTATION CURRENTLY UTILIZES HEAVY IMMUNOSUPPRESSION (IS) WITH SEVERE TOXIC SIDE EFFECTS. OUR PROGRAM UNIQUELY EMPLOYS HISTOCOMPATIBLE INBRED PIGS WITH GENETIC MODIFICATIONS (GMS) AIMED AT ACHIEVING DONOR-SPECIFIC IMMUNOLOGIC UNRESPONSIVENESS (DSU) BY FIRST TRANSPLANTING CELLS AND TISSUES, FOLLOWED BY TRANSPLANTATION OF HISTOCOMPATIBLE ORGANS FROM THE SAME PIG LINE. IN TWO HIGHLY INTEGRATED PROJECTS AND THREE CORES, WE WILL UTILIZE TWO UNIQUE PLATFORMS FOR INDUCING DSU, NAMELY XENOGENEIC MIXED HEMATOPOIETIC CHIMERISM (MC) AND PORCINE THYMUS (THY) TRANSPLANTATION. USING THESE, WE HAVE ACHIEVED XENOTRANSPLANTATION WITHOUT IMMUNOSUPPRESSIVE MAINTENANCE (XTWIM) IN HUMAN IMMUNE SYSTEM (HIS) MICE AND IS WEANING TO MONOTHERAPY IN NON-HUMAN PRIMATES (NHPS). IN PROJECT 1, “RE-EDUCATION OF ADAPTIVE AND INNATE HUMAN ANTI-PIG IMMUNE RESPONSES IN HUMAN IMMUNE SYSTEM MICE”, WE WILL OPTIMIZE XTWIM IN HUMAN IMMUNE SYSTEMS BY COMBINING PORCINE THY TRANSPLANTATION AND XENOGENEIC MC. WHILE BOTH APPROACHES CENTRALLY TOLERIZE HUMAN T CELLS TO THE SOURCE PIG, XENOGENEIC MC ALSO TOLERIZES HUMAN NK CELLS AND NAB-PRODUCING B CELLS. THY TRANSPLANTATION GENERATES TREGS TO OVERCOME RESIDUAL PERIPHERAL IMMUNITY TO THE PIG. WE HAVE NOW DEMONSTRATED THAT COMBINED MC AND PORCINE THY TRANSPLANTATION CAN OVERCOME LIMITATIONS IN INTERACTIONS WITH HUMAN APCS IN THE PERIPHERY IF A HUMAN THYMUS IS ALSO PRESENT. WE WILL CHARACTERIZE THE HUMAN IMMUNE SYSTEMS DEVELOPED WITH THIS APPROACH, DETERMINE THE MECHANISMS OF DSU AND OPTIMIZE CONDITIONING FOR TRANSLATION INTO THE LARGE ANIMAL MODELS IN PROJECT 2 AND ULTIMATELY PATIENTS. PROJECT 2, “ACHIEVING XTWIM THROUGH THYMIC TRANSPLANTATION AND MIXED CHIMERISM IN NHPS”, WILL ADVANCE THY TRANSPLANTATION AND XENOGENEIC MC TO ACHIEVE XTWIM IN NHPS. WE HAVE ACHIEVED REMARKABLE LONG-TERM SURVIVAL OF GALT KNOCKOUT PORCINE KIDNEYS GRAFTED AS COMPOSITE THYMOKIDNEY (TK) GRAFTS. PROJECT 2 WILL OPTIMIZE XTWIM INDUCTION BY COMBINING THIS APPROACH WITH MC IN A PRE-CLINICAL NHP MODEL. WE WILL MODIFY IS INDUCTION, AIMING TO ENHANCE TREG-MEDIATED SUPPRESSION OF PRE-EXISTING RESPONSES. WE WILL EXPLORE THE USE OF FETAL THY TISSUE, CAPITALIZING ON OUR INBRED PIG LINE, AIMING TO ACCELERATE RECIPIENT THYMOPOIESIS AND DSU IN TK GRAFTS. FOR ANIMALS WITH HIGHER NAB LEVELS, WE WILL UTILIZE GALT KO PIGS WITH ADDITIONAL GMS AND USE A NORMOTHERMIC PERFUSION (NMP) DEVICE TO INVESTIGATE NOVEL GMS. WE WILL EVALUATE STRATEGIES (FROM PROJECT 1 AND CORE C) TO PROTECT PIG BM FROM BABOON INNATE IMMUNITY, THEREBY COMBINING MC AND TK TRANSPLANTATION. CORE A, WILL PROVIDE ADMINISTRATIVE COORDINATION OF THE PROGRAM. CORE B WILL PROVIDE QUALITY-CONTROLLED ANIMALS, PORCINE CELLS AND TISSUES TO BOTH PROJECTS AND PRODUCE NEW, HIGHLY INBRED HISTOCOMPATIBLE AND GM PIGS. CORE C CONSTRUCTS UNIQUE GM PIGS AIMED AT PROMOTING XTWIM. COLLECTIVELY, THESE PROJECTS AND CORES WILL SYNERGIZE TO ADVANCE CLINICAL XTWIM.
$3,040,700
MINIMALLY ORCHESTRATED STORAGE TECHNOLOGY FOR DURATION ADDITION TO ELECTRICITY STORAGE
$1,878,394
HUMAN BONE-MARROW MODEL FOR RESPONSE NETWORK STUDIES OF LOW DOSE / LOW DOSE-RATE RADIATION EXPOSURES
$1,499,943
NOVEL PHASES AND SELF-ORGANIZATION IN QUANTUM MATTER OF ULTRACOLD DIPOLAR MOLECULES
$1,498,428
WIRELESS, IMPLANTABLE INTERFACE TO VISUAL CORTEX
$1,435,449
TWO-DIMENSIONAL HEAVY FERMION MATERIALS
$1,433,273
DEEPLY SUBWAVELENGTH METABOLIC IMAGING WITH AVALANCHING NANOPARTICLES
$1,290,000
POLARONIC ELECTRON CRYSTALS IN 2D MOIRÉ MATERIALS
$1,110,905